# Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy

> **NCT02004184** · PHASE3 · TERMINATED · sponsor: **Norwegian University of Science and Technology** · enrollment: 230 (actual)

## Conditions studied

- Carcinoma, Non-small-cell Lung

## Interventions

- **DRUG:** maintenance pemetrexed
- **DRUG:** pemetrexed at progression

## Key facts

- **NCT ID:** NCT02004184
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 230 (ACTUAL)
- **Why stopped:** Poor enrollment due to the introduction of immunotherapy
- **Last updated:** 2020-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004184, "Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02004184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*